Sunday, June 21, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 942 of 1,261

  1. US 8076412

    Water-soluble polymer alkanals

    Nektar Therapeutics · Granted Dec 13, 2011 · Expires Dec 8, 2031

    granted

  2. US 8076353

    Inhibition of VEGF translation

    PTC THERAPEUTICS, INC. · Granted Dec 13, 2011 · Expires Dec 8, 2031

    granted

  3. US 8076372

    Acythiols and component thiol compositions as anti-HIV and anti-retroviral agents

    The Government of the United States · Granted Dec 13, 2011 · Expires Dec 8, 2031

    granted

  4. US 8076343

    Benzimidazoles useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Dec 13, 2011 · Expires Dec 8, 2031

    granted

  5. US 8076352

    Administration of carboline derivatives useful in the treatment of cancer and other diseases

    PTC THERAPEUTICS, INC. · Granted Dec 13, 2011 · Expires Dec 8, 2031

    granted

  6. US 8076470

    VMP-like sequences of pathogenic Borrelia species and strains

    The Board of Regents of the University of Texas System · Granted Dec 13, 2011 · Expires Dec 8, 2031

    granted

  7. US 8076357

    Compositions of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide

    Vertex Pharmaceuticals Incorporated · Granted Dec 13, 2011 · Expires Dec 8, 2031

    granted

  8. US 8076451

    Selective delivery of molecules into cells or marking of cells in diseased tissue regions using environmentally sensitive transmembrane peptide

    Board of Governors for Higher Education, State of Rhode Island and Providence Plantations · Granted Dec 13, 2011 · Expires Dec 8, 2031

    granted

  9. AU 2010255748

    Stabilised composition comprising at least one adrenergic compound

    ALK AG [DK] · Granted Dec 8, 2011 · Expires Dec 3, 2031

    granted

  10. US 8071323

    Human monoclonal antibodies that bind human insulin like growth factors and their use

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Dec 6, 2011 · Expires Dec 1, 2031

    granted

  11. US 8071618

    Caspase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Dec 6, 2011 · Expires Dec 1, 2031

    granted

  12. US 8071746

    Isolated nucleic acid molecule encoding a peptide or peptide analog comprising the SEQ ID No. 3

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 6, 2011 · Expires Dec 1, 2031

    granted

  13. US 8071087

    Reovirus for the treatment of cellular proliferative disorders

    ONCOLYTICS BIOTECH INC. · Granted Dec 6, 2011 · Expires Dec 1, 2031

    granted

  14. US 8071113

    Live, oral vaccine for protection against Shigella dysenteriae serotype 1

    The United States of America, as represented by the Department of Health and Human Services · Granted Dec 6, 2011 · Expires Dec 1, 2031

    granted

  15. US 8071109

    VMP-like sequences of pathogenic Borrelia

    The Board of Regents of the University of Texas System · Granted Dec 6, 2011 · Expires Dec 1, 2031

    granted

  16. US 8071118

    Method of inducing cell proliferation using fibroin

    UNIVERSITY OF CONNECTICUT · Granted Dec 6, 2011 · Expires Dec 1, 2031

    granted

  17. US 8071130

    Solid preparation

    Takeda Pharmaceutical Company Limited · Granted Dec 6, 2011 · Expires Dec 1, 2031

    granted

  18. US 8071074

    Preventing airway mucus production by administration of EGF-R antagonists

    The Regents of the University of California · Granted Dec 6, 2011 · Expires Dec 1, 2031

    granted

  19. US 8071084

    Vaccine for protection against Shigella sonnei disease

    The United States of America, as represented by the Department of Health and Human Services · Granted Dec 6, 2011 · Expires Dec 1, 2031

    granted

  20. US 8070467

    Polymer microspheres/nanospheres and encapsulating therapeutic proteins therein

    Aphios Corporation · Granted Dec 6, 2011 · Expires Dec 1, 2031

    granted

  21. US 8071107

    Nucleic acids encoding modified human immunodeficiency virus type 1 (HIV-1) group M consensus envelope glycoproteins

    The Regents of the University of California · Granted Dec 6, 2011 · Expires Dec 1, 2031

    granted

  22. US 8071137

    Method for treatment of cartilage disorders with centella extract

    Advanced Technologies and Regenerative Medicine, LLC · Granted Dec 6, 2011 · Expires Dec 1, 2031

    granted

  23. US 8071603

    Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitors

    Xenon Pharmaceuticals Inc. · Granted Dec 6, 2011 · Expires Dec 1, 2031

    granted

  24. US 8071807

    Antagonists of prostaglandin D2 receptors

    Panmira Pharmaceuticals, LLC · Granted Dec 6, 2011 · Expires Dec 1, 2031

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.